On 22 July 2020, Smile Study started officially the operational phase of the projects with the training on the equipments and the visiting of first subjects enrolledDr. Elbert Waller of the Inspektor Research Systems has been welcomed in Catania for for the conduction of a training on the latest innovative technologies in dental diagnostic
Talking about tobacco harm reduction means embracing a plurality of behaviors, choices and products that can be confusing. We have deepened the subject with Dr. Renée O’Leary, author of the paper and COEHAR researcher
The article highlights why harm reduction is important, what are the ways to achieve harm reduction, particularly the use of snus, heated tobacco products and e-cigarettes and what are the barriers to use of such alternatives. This article is not a systematic or narrative review; it is an overview of recent studies on these products or devices. Industry conducted or funded studies were excluded from the review.
Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Unfortunately, socio-cultural and economics barriers, such as heavy taxation, misperceptions about nicotine and unsubstantiated fears of youth addiction, prevent low risk products to become accessible to all and a good choice for those who want to quit smoking.
The Coehar Director, Giovanni Li Volti and the Co-project Leader for Replica, Dr. Massimo Caruso have organized a tour to all the international partners of the project to harmonize the protocols of the study for the first year of the Replica Project
The Replica Project aim is to replicate the most important studies in the field of Tobacco Harm Reduction (THR)The following video refers to one of the stop of the Replica Tour: Giovanni Li Volti and the Co-project Leader Massimo Caruso were in Oman.
A new study published in the journal "Therapeutic Advances in Chronic Disease" provides important insight to the issue of smoking and COVID-19. The number of smokers with severe COVID-19 that requires hospitalization is by far lower than expected based on population smoking rates. The very few smokers who are eventually hospitalized have higher odds for severe disease and adverse outcome.
The findings from a survey conducted by COEHAR researchers on almost 2000 participants showed a slight decrease in the consumption of cigarettes during the lockdown period and an increase in the purchase of products such as cigarettes and e-liquid
The organisers of the Global Forum on Nicotine (GFN), KAC Communications, are launching an online version of GFN20 which will take place on Thursday 11 and Friday 12 June following the cancellation of the face-to-face event in Warsaw due to COVID-19
Catania, 8 June 2020 - The selection procedure for the award of 4 Research Fellowships is open to young graduates in various discipline: the deadline is June 26, 2020. The selection is part of the activities and research projects promoted by the COEHAR, the Center of Excellence for the Accelleration of Harm Reduction of the University of Catania, founded by Prof. Riccardo Polosa.
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.